Document is current
Any future updates will be listed below
-
Authors
Beksac, Meral
Samra, Mohamed
Abduljalil, Omar
AAL Yaseen, Hasan
Besisik, Sevgi
Seval, Guldane Cengi̇z
Elghandour, Ashraf
Fathy, Gamal
Özsan, Güner Hayri
Marashi, Mahmoud
Sevindik, Ömür Gökmen
Taha, Ruba Yaseen Ibrahim
Aggarwal, Bhumika
Mouro, Jorge
Phansalkar, Abhay
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals
- License Information
-
More Information
Article History
Received: 1 December 2025
Accepted: 18 February 2026
First Online: 26 March 2026
Declarations
:
: Meral Beksac: honoraria from BMS, Janssen; consulting or advisory role from GSK, Takeda, Amgen, Janssen, and Menarini. Hasan AAL Yaseen: received honoraria from GSK, Amgen, Novartis, and Abbvie. Guldane Cengi̇z Seval: honoraria from BMS, Janssen, Amgen, Menarini, Pfizer, Takeda, and Sanofi; consulting or advisory role from GSK, Janssen, Menarini, Pfizer, BMS, Takeda, and Sanofi. Ashraf Elghandour: received payment/honoraria from J&J, AstraZeneca, Novartis, and Sanofi. Mahmoud Marashi: received payment for advisory board and lectures for Johnson & Johnson, Sanofi, Pfizer, Amgen, Abbvie, Eva Pharma, and Takeda. Bhumika Aggarwal, Jorge Mouro, Abhay Phansalkar: employees of GSK and hold financial equities in GSK. Mohamed Samra, Omar Abduljalil, Sevgi Besisik, Gamal Fathy, Güner Hayri Özsan, Ömür Gökmen Sevindik, and Ruba Yaseen Ibrahim Taha: none.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
